BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Seattle Genetics

About Seattle Genetics

Seattle Genetics is a biotechnology company focused on developing monoclonal antibody (mAb)-based therapeutics for cancer and immunologic diseases.

 

CLINICAL TRIAL DATA

 

PIPELINE

SGN-30 is a genetically engineered antibody targeting the CD30 antigen, which is expressed on many types of hematologic malignancies such as Hodgkin's disease and some types of non-Hodgkin's lymphoma.

SGN-15 is an antibody-drug conjugate (ADC) composed of a genetically engineered antibody targeted to an antigen that is conjugated to doxorubicin.A phase II clinical trial has been completed using SGN-15 for the treatment of non-small cell lung cancer in combination with Taxotere.

SGN-40 is a humanized antibody targeted to the CD40 antigen -- target sites are hematologic malignancies such as multiple myeloma and non-Hodgkin's lymphoma.

 

Home Page

Key Statistics for Seattle Genetics

Basic Chart for Seattle Genetics

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com